Sofinnova Venture Partners IX, L.P.

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

Sofinnova Venture Partners IX, L.P. sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.

Stakes it holds

Sofinnova Venture Partners IX, L.P. has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).

• ArriVent BioPharma, Inc.SCHEDULE 13G/A Mar 5, 2026²
• NextCure, Inc.SCHEDULE 13D/A Mar 5, 2026³
• Galera Therapeutics, Inc.SC 13D/A Feb 6, 2023 to Feb 20, 2024⁴